Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape

Fig. 5

The immune landscape of ER+/PR−/HER2− breast cancer. A The immune landscape: each point represents a patient with colors corresponding to the immune subtype identified previously. B Patients of cluster 2 could be further stratified into three subgroups based on their location in the immune landscape. C Gene programme expression patterns were shown to illustrate the intra-cluster heterogeneity of cluster 2. D The three subgroups of patients stratified by the immune landscape in cluster 2 were associated with distinct prognosis

Back to article page